Year 2019: top* 10 papers with the highest R-portion

Topic: Epidemiology and Management of NAFLD

* The top 5% of entries has been removed to reduce statistical anomalies. Further fine-tuning, filtering, and error cleaning are in progress.

Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications

YCR = 2019 / 143 /  8.06 

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism

YCR = 2019 / 182 /  7.97 

Lifestyle modification in NAFLD/NASH: Facts and figures

YCR = 2019 / 155 /  7.97 

Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease

YCR = 2019 / 145 /  7.96 

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview

YCR = 2019 / 142 /  7.90 

Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease

YCR = 2019 / 145 /  7.90 

Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in <i>db</i>/<i>db</i> mice

YCR = 2019 / 140 /  7.86 

Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States

YCR = 2019 / 149 /  7.78 

Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes M...

YCR = 2019 / 172 /  7.75 

Cohort Profile: Ravansar Non-Communicable Disease cohort study: the first cohort study in a Kurdish population

YCR = 2019 / 104 /  7.75